Cometriq

Cometriq (Cabozantinib) is an oral medication used to manage certain types of cancer. This prescription drug is designed to target specific pathways involved in tumor growth and spread.

Cometriq is primarily used in the treatment of advanced thyroid cancer and other specific cancers. It works by inhibiting the growth and spread of cancer cells, making it a targeted therapy option. Patients often wonder, 'What is Cometriq used for?' and the answer lies in its ability to interfere with tumor progression.

Common effects of Cometriq may include fatigue, diarrhea, and nausea. Some users also report appetite loss and hand-foot syndrome. These effects can vary widely among individuals and are not exhaustive.

Cometriq should be handled with care and stored as directed. It is important to follow the advice of a healthcare provider regarding its use. Pregnant women and those with certain medical conditions should exercise caution.

Cometriq may interact with other medications, including those that affect liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also influence its effectiveness.